Copy Number
The putative cancer-associated PDGs driven by SCNAs in each cancer type were identified by four criteria: 1) located in a peak region of a significantly recurrent focal SNCA locus estimated by the genomic identification of significant targets in cancer (GISTIC2) algorithm, (q≤0.25); 2) altered with high frequency and large amplitude (G-score ≥0.1); 3) mRNA reliably detected in at least 10% of tumor specimens in the given cancer type (90th percentile of FPKM value ≥1); and 4) mRNA significantly and positively correlated with copy numbers (Pearson P-value less than 0.001).
Showing page 23 |
first page | previous page | next page | last page |
Overall_Gscore | No. of Cancer Types | ||||
HGNC Symbol | Ensembl Gene ID | Amplification | Deletion | Amplification | Deletion |
COMP | ENSG00000105664 | 0.00 | 0.00 | 0 | 0 |
GAPDHS | ENSG00000105679 | 0.00 | 0.00 | 0 | 0 |
MAG | ENSG00000105695 | 0.00 | 0.00 | 0 | 0 |
HAMP | ENSG00000105697 | 0.00 | 0.00 | 0 | 0 |
SCN1B | ENSG00000105711 | 0.00 | 0.00 | 0 | 0 |
TFPI2 | ENSG00000105825 | 0.25 | 0.00 | 1 | 0 |
NAMPT | ENSG00000105835 | 0.00 | 0.00 | 0 | 0 |
PIK3CG | ENSG00000105851 | 0.00 | 0.00 | 0 | 0 |
PON3 | ENSG00000105852 | 0.00 | 0.00 | 0 | 0 |
PON2 | ENSG00000105854 | 0.00 | 0.00 | 0 | 0 |
ITGB8 | ENSG00000105855 | 0.13 | 0.00 | 1 | 0 |
NPVF | ENSG00000105954 | 0.00 | 0.00 | 0 | 0 |
FKBP14 | ENSG00000106080 | 0.00 | 0.00 | 0 | 0 |
STX1A | ENSG00000106089 | 0.12 | 0.00 | 1 | 0 |
NOD1 | ENSG00000106100 | 0.00 | 0.00 | 0 | 0 |
EPHB6 | ENSG00000106123 | 0.00 | 0.00 | 0 | 0 |
GHRHR | ENSG00000106128 | 0.00 | 0.00 | 0 | 0 |
CASP2 | ENSG00000106144 | 0.32 | 0.14 | 2 | 1 |
CCL24 | ENSG00000106178 | 0.00 | 0.00 | 0 | 0 |
NPTX2 | ENSG00000106236 | 0.00 | 0.00 | 0 | 0 |
Showing page 23 |
first page | previous page | next page | last page |